课题基金 / 基金详情

Development of Molecular Targeting Agents Based on Analysis Oncogenesis with Homeobox Gene Mutation

Development of Molecular Targeting Agents Based on Analysis Oncogenesis with Homeobox Gene Mutation
基于同源盒基因突变分析肿瘤发生的分子靶向药物的开发
批准号:
16390373
负责人:
ERIGUCHI Masazumi
金额:
$9.34万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005

项目摘要

项目成果

ERIGUCHI Masazumi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We performed analysis of mechanisms of oncogenesis based on homeobox gene mutation in cancer cell lines. We selected cervical cancer caused of oncogenesis by the infection of human papilloma virus as the model. The HPV genotyping of several cervical cancer cell lines were studied with DNA microarray analysis. Twenty-seven HPV gene genotypes were searched for infection to cervical cancer cell lines (HPV-6,11,16,18,31,33,34,35,39,40,42,43,44,45,51,52,54,56,58,59,62,66,67,68,69,70,72). The HPV genotyping of cervical cancer cell lines as below ; Hela : HPV Type18, Hela S3 : HPV Type18, ME 180 : HPV Negative, Caski : HPV Type 16, SKG IIIa : HPV Type16, SKG IIIb HPV Type 16, Boku HPV Type 16, KF HPV Negative. HPV type 16 and type 18 are recognized as oncogenic virus type in cervical cancers. We prepared inversed primer of HPV type16(MY11 : CC GTT ATG TCC CTG TGC, GP6+ : TG ATT TAC AGT TTA TTT TTC), and performed Inverse PCR to detect the sequence of HPV 16 in cancer cell lines infected HPV 16 with amprifining the undetected sequence of genome of cancer cells.We also performed DNA microarray analysis to detect oncogeneic genes, metastatic genes, and multidrug resistant genes in cancer cell lines for developing molecular targeting agents. We determined the novel two genes, TBCE and CITED2, that have the functions as multidrug resistant genes.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
DNA Microarray Analysis Specific to Chemikine /Ckemokine Receptor as the Marker of Metasis in Gastric Cancer Cell Lines
DNA 微阵列分析特异于作为胃癌细胞系转移标记的趋化因子/Ckemokine 受体
DOI: --
发表时间: 2005
期刊: Proceeding of 6th International Gastric Cancer Congress Medimond Press
影响因子: --
作者: [H.Yanagie, M.Eriguchi et al.]
通讯作者: M.Eriguchi et al.
Development of molecular targeting therapy using cancer permeabile WOW emulsion by membrane emulfication
  • 批准号:
    18390360
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $11.42万
  • 财政年份:
    2006
  • 负责人:
    ERIGUCHI Masazumi
  • 依托单位:
Study for wound healing in HIV-infected patients
  • 批准号:
    06671185
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 资助金额:
    $1.34万
  • 财政年份:
    1994
  • 负责人:
    ERIGUCHI Masazumi
  • 依托单位:
海外基金